SCHEMBL11048879

SCHEMBL11048879

CN(C)C(=O)N1CCN(c2ccccc2)CC1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 1/20 0.59
ALDH1A1 P00352 5/20 0.59
MEN1 O00255 3/20 0.59
KMT2A Q03164 3/20 0.59
USP2 O75604 2/20 0.59
TSHR P16473 2/20 0.59
MAPT P10636 4/20 0.56
LMNA P02545 3/20 0.56
NPSR1 Q6W5P4 1/20 0.56
CYP2C9 P11712 1/20 0.56
CYP2C19 P33261 1/20 0.56
AKR1C3 P42330 1/20 0.56
NPC1 O15118 1/20 0.55
RAB9A P51151 1/20 0.55
MAPK1 P28482 2/20 0.54
POLB P06746 2/20 0.53
SLC6A7 Q99884 1/20 0.53
HTR1A P08908 1/20 0.51
HTR7 P34969 1/20 0.51
HTT P42858 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11056916 0.85 HRH3 (0.56) HRH3ALDH1A1MEN1KMT2AUSP2
SCHEMBL22542064 0.84 AKR1C3 (0.59) ALDH1A1KMT2AUSP2MAPTLMNA
SCHEMBL11055466 0.83 HRH3 (0.65) HRH3ALDH1A1MEN1KMT2AUSP2
SCHEMBL6150875 0.83 GFER (0.68) HRH3ALDH1A1MEN1KMT2AUSP2
SCHEMBL30508269 0.83 AKR1C3 (0.58) HRH3ALDH1A1MEN1KMT2AUSP2
SCHEMBL1811256 0.83 GFER (0.68) HRH3ALDH1A1MEN1KMT2AUSP2
SCHEMBL11049938 0.83 KMT2A (0.56) HRH3ALDH1A1MEN1KMT2AUSP2
SCHEMBL21169221 0.82 DRD2 (0.52) HRH3ALDH1A1MEN1KMT2AUSP2
SCHEMBL20883570 0.81 PANK3 (0.56) HRH3ALDH1A1MEN1KMT2ATSHR
SCHEMBL1483601 0.81 MAPT (0.63) ALDH1A1MEN1KMT2AMAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11541041-B1 Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, Rasopathies, and fibrotic disease SHY Therapeutics LLC (US) 2023-01-03 US disclosed
US-4446133-A ANTIARTHRITIC AGENTS Misuitoatsu Chemicals, Inc. (JP) 1984-05-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11541041-B1 Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, Rasopathies, and fibrotic disease HRAS, KRAS, NRAS HRH3 2661/4885ALDH1A1 3448/4885MEN1 1612/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.